MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), of which MMJ holds 53,333,333 shares, has announced the closure of its C$40,250,000 bought deal offering.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 31 December 2017.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has received results from the first 10 patients who participated in the Phase 2 clinical trial undertaken by MMJ's wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Ltd.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has entered into an agreement to acquire a strategic stake in private, Canadian-based healthcare company Dosecann Inc., via the proposed placement of C$2.5 million in secured convertible debenture units.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its partly-owned TSX-V listed subsidiary, Harvest One Cannabis Inc. (CVE:HVST), has released two announcements regarding its intentions to undertake a fully underwritten short form prospectus offer to raise up to $25,000,000 initially and then subsequently increased to $35,000,000 (excluding over-allotments) due to strong investor demand.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an operational update in relation to its wholly-owned horticultural subsidiary United Greeneries Ltd.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise shareholders that the Company welcomes the recent announcement (4 January 2018) made by Federal Government Health Minister Mr. Greg Hunt outlining the Government's plans to allow the export of medicinal cannabis products from Australia.
